Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank27
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
-4.28%
↓ 131% vs avg
Percentile
P27
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
13.75%
Historical baseline
PeriodValue
Q4 2025-4.28%
Q3 202587.51%
Q2 2025-5.48%
Q1 2025-4.09%
Q4 2024-4.90%
Q3 2024-4.32%
Q2 202467.77%
Q1 202432.73%
Q4 20230.00%
Q3 20230.00%
Q2 20230.00%
Q1 20230.00%